Gilead Sciences (GILD) EBIT (2009 - 2026)
Gilead Sciences (GILD) reported EBIT of -$10.39 billion for Q2 2026, compared with $2.47 billion a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) EBIT (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Gilead Sciences' EBIT came in at -$2.5 billion; for FY2025, it came in at $10.02 billion, up 503.0% from FY2024.
- EBIT has a five-year compound annual growth rate of 19.7% (FY2020 to FY2025).
- By year, EBIT came in at $1.66 billion in FY2024 (-78.1%), $7.61 billion in FY2023 (+3.8%), $7.33 billion in FY2022 (-26.1%) and $9.92 billion in FY2021 (+143.6%).
- The Q2 2026 figure ranks as the lowest quarterly EBIT in data going back to Q1 2009.
- Year over year, EBIT gained in three of the last six quarters, with growth averaging 41.8%.
- The high point for year-over-year EBIT in five years was Q1 2023 (growth of 765.5%); the low point was Q1 2022 (a decline of 93.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.59 billion (Q1 2026), $1.98 billion (Q4 2025) and $3.33 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.39 Bn |
| Mar 31, 2026 | 2.59 Bn |
| Dec 31, 2025 | 1.98 Bn |
| Sep 30, 2025 | 3.33 Bn |
| Jun 30, 2025 | 2.47 Bn |
| Mar 31, 2025 | 2.24 Bn |
| Dec 31, 2024 | 2.45 Bn |
| Sep 30, 2024 | 888.00 Mn |
| Jun 30, 2024 | 2.64 Bn |
| Mar 31, 2024 | -4.32 Bn |
| Dec 31, 2023 | 1.61 Bn |
| Sep 30, 2023 | 2.62 Bn |
| Jun 30, 2023 | 1.67 Bn |
| Mar 31, 2023 | 1.71 Bn |
| Dec 31, 2022 | 2.27 Bn |
| Sep 30, 2022 | 2.84 Bn |
| Jun 30, 2022 | 2.03 Bn |
| Mar 31, 2022 | 197.00 Mn |
| Dec 31, 2021 | 940.00 Mn |
| Sep 30, 2021 | 3.84 Bn |
API Access
Gilead Sciences EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();